ID   SerBob
AC   CVCL_2720
SY   Serum-adapted Bob
DR   ECACC; 10021101
DR   Wikidata; Q54952814
RX   PubMed=19544327;
CC   Characteristics: Adapted to growth in a medium containing serum.
CC   Karyotypic information: Has lost chromosome Y (from parent cell line).
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
ST   Source(s): ECACC=10021101
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 9,14
ST   D16S539: 10,12
ST   D5S818: 13
ST   D7S820: 10,11
ST   TH01: 9
ST   TPOX: 8,10
ST   vWA: 17
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2317 ! Bob
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 12
//
RX   PubMed=19544327; DOI=10.1002/pros.20997;
RA   Attard, Gerhardt
RA   Rizzo, Sian
RA   Ledaki, Ioanna
RA   Clark, Jeremy
RA   Reid, Alison H.M.
RA   Thompson, Alan
RA   Khoo, Vincent
RA   de Bono, Johann Sebastian
RA   Cooper, Colin S.
RA   Hudson, David L.
RT   "A novel, spontaneously immortalized, human prostate cancer cell line,
RT   Bob, offers a unique model for pre-clinical prostate cancer studies.";
RL   Prostate 69:1507-1520(2009).
//